Objective: Congestive heart failure (CHF) is accompanied by impaired peripheral blood flow and endothelial dysfunction with decreased release of nitric oxide (NO). Strong evidence supports the existence of another vasodilatory substance, endothelium derived hyperpolarising factor (EDHF), which has not previously been studied in CHF. Method: CHF was induced by left coronary artery ligation resulting in a reproducible myocardial infarction in Sprague Dawley rats. Vasodilatory responses to acetylcholine and extracellular nucleotides (ATP, ADPbS, ADP and UTP) were examined in cylindrical segments of the mesenteric artery, precontracted with noradrenaline. The combined NO-and EDHF-dilatation (after inhibition of cyclo-oxygenase pathways) was called ''total dilatation'', as indomethacin had only minor effects in this system. NO-dilatation was studied in segments pretreated with indomethacin and the indomethacin (10 M) and L-NOARG (10 M). Results: EDHF-dilatations in CHF were strongly up-regulated for ACh (36% vs. 73%; sham vs. CHF operated rats), ADPbS (10% vs. 42%), ADP (0% vs. 21%) and UTP (3% vs. 35%). These dilatations were abolished by a combination of charybdotoxin and apamin, confirming that they were mediated by EDHF. The NO-dilatations on the other hand were down-regulated in CHF as compared to sham operated rats for ACh (93% vs. 76%; sham vs. CHF operated rats), ADPbS (61% vs. 37%). ADP (60% vs. 30%), ATP (49% vs. 34%) and UTP (65% vs. 47%), while a minor decrease was seen in the total dilatation for ACh (87% vs. 75%; sham vs. CHF operated rats), ADPbS (47% vs. 42%), ADP (59% vs. 39%), ATP (52% vs. 39%) and UTP (59% vs. 44%).
Introduction
Endothelial cells induce vasodilatation when stimulated by acetylcholine (ACh) and extracellular nucleotides such Congestive heart failure (CHF) is characterised by as ATP, UTP and ADP. The dilatory mediators, released by reduced cardiac function resulting in inadequate tissue ACh, have so far mainly been characterised as nitric oxide perfusion. CHF also induces changes in several carfrom circulating vasoconstrictors such as catecholamines 60 mg / kg i.p., the rats were intubated and artificially [7, 8] , endothelin [9, 10] , arginine vasopressin [11, 12] , ventilated with a respirator (Carlsson ventilator, No 8908, cytokines such as TNFa [7, 13, 14] , or an altered endotheliMolndal, Sweden). A left thoracotomy was performed, al shear stress [15, 16] . Investigation of endothelial function exposing the left ventricular wall. The left coronary artery and stimulated release of NO in CHF has classically been was ligated by positioning a suture between the pulmonary performed by the use of ACh [17] . It has been shown that artery outflow tract and the left atrium. The lungs were ACh-induced NO-release is decreased in CHF, and that thereafter hyperinflated using positive end-expiratory presendothelium-dependent dilatation of resistance vessels is sure, the thorax was immediately closed and the rats were blunted in patients with severe CHF [18] [19] [20] . In conductallowed to recover for 4-8 weeks before the experiments ance vessels, flow-dependent dilatation is reduced in CHF, were started. Rats which underwent the same surgical reflecting endothelial dysfunction. Previous reports sugprocedure, but without coronary artery ligation, served as gests that decreased levels of NO may be associated with controls (sham operated rats). Early mortality (1 day) after increased activity of EDHF, that in a compensatory surgery was 10% and late mortality (1 month) 2%. manner, maintains endothelial vasodilator function during vascular diseases such as hypertension [21] , diabetes [22] 2.3. Evaluation of infarction size and hypercholesterolemia [23] .
ATP is stored in and may be released from most cells, To confirm the induced myocardial infarction in the e.g. endothelial cells exposed to hypoxia or shear stress as operated animals a histological follow-up was performed. well as trombocytes during aggregation. ATP is also a During the tissue preparation (see below) the hearts from co-transmitter with noradrenaline (NA) in perivascular the control and CHF rats were removed and immersed into sympathetic nervous system [24] , which is known to a 6% formaline solution. The ventricular region of the possess increased activity in CHF [25, 26] . Recent studies heart was then cut from the apex to the base in four slices have shown that plasma adenosine levels are increased in and from each slice 10 mm thin sections were prepared and patients with ischemic and non-ischemic chronic CHF, and stained for microscopical evaluation. Photographs were that adenosine-levels are correlated to the severity of the made at 310 magnification and the endocardial circumferdisease [27] . Since circulating (adenosine triphosphate) ence of the left ventricle and the extent of the fibrotic area ATP is rapidly degraded to adenosine by ectonucleotidfrom each slice was measured. Infarct size was evaluated ases, present preferentially on endothelial cells ( [28] ), the according to [29] , i.e. the fibrotic fraction in per cent of the elevation of plasma adenosine may reflect an increased total cross-sectional endocardial circumference of the left release of ATP in CHF. Thus, it is of considerable interest ventricle. Rats with a myocardial infarction comprising to study the cardiovascular effects of extracellular ATP in more than 30% of the left ventricular wall were included in CHF, in order to elucidate possible adaptations to its the study. responses. The present study was designed to examine endothelial function in CHF by investigating the potential 2.4. In vitro experiments alterations in ACh and P2Y-receptor stimulated EDHFand NO-dilatation. To our knowledge there are no previous The rats were anaesthetised by inhalation of CO 2 studies on EDHF-dilatation in CHF.
(carbon dioxide), and killed by a cardiac cut. The mesenteric artery was gently removed and immersed in a cold oxygenated bicarbonate based buffer solution (for com-2. Material and methods position, se below) where after the superior mesenteric artery before branching was dissected free of adhering 2.1. Experimental animals tissue under a microscope. The vessels were cut into cylindrical segments (2-3 mm long) which were immediExperiments were conducted on male Sprague-Dawley ately used in the experiments. Each cylindrical segment rats (ALAB, Sollentuna, Sweden) weighing approximately was mounted on two L-shaped metal prongs, one of which 500 g (2-3 months old). All animals were maintained on was connected to a force displacement transducer (FT03C) standard rat pellets and tap water ad libitum and housed in for continuous recording of the isometric tension, and the cages in groups of five animals, at 1268C, with 60%
other to a displacement device [30] . Special care was taken to ensure that the endothelium was (NA, 10 -10 Tables) . were made between the responses in different vessel max segments. Antagonists were administered 30 min before application of agonists. All experiments were performed with indomethacin present to abolish prostacyclin-induced 3. Results dilatory effects. Endothelium-denudation was performed on the dissected intact vessel before mounting by perfusion 3.1. CHF status for 5 s with 0.1% Triton X followed by another 5 s of perfusion with a buffer solution using a fine needle. Other signs of congestive heart failure Congestion of the lungs and abdominal organs and of The EDHF-mediated dilatory response was studied after the portal and the lienal veins were seen in the CHF eliminating the prostacyclin-and NO-mediated dilatations operated rats, supporting the establishment of congestive by administration of indomethacin and L-NOARG, while heart failure. These observations correspond with our the NO-dilatation was studied in artery segments pretreated findings of increased heart-(0. Fig. 1a , b and c, the total dilatation for CHF as compared to sham 3.2.2. Indomethacin was 78%. The relative shares of the dilatory mediators was Indomethacin did not affect the dilatory responses to any in CHF, 57% for NO and 43% for EDHF, and in sham of the agonists significantly (reduction of dilatation ,5%), operated rats 77% for NO and 23% for EDHF (Fig. 6) . indicating a very minor contribution of cyclo-oxygenase products.
Myocardial infarction size

Discussion
Inhibition of NO, EDHF and cyclo-oxygenase pathways
The most interesting finding was that this model of When the artery segments were pretreated with a non-atherosclerotic CHF induced an up-regulation of the combination of indomethacin, L-NOARG, charybdotoxin
ACh and P2Y-receptor stimulated EDHF-dilatation, while and apamin, all dilatory responses were abolished in both the NO-dilatation was down-regulated. CHF and sham operated rats, indicating that the L-NOARG and indomethacin resistant dilatation was indeed 4.1. The CHF model mediated by EDHF.
A heart failure model was used where the left anterior 3.2.4. Total dilatation descending coronary artery was ligated inducing an acute Dilatations recorded with only indomethacin present infarction, where after the rats were left to recover for 4-8 were called ''total dilatation'' as indomethacin only had weeks. During this period a heart failure state was deminor effects in this system. CHF induced a minor veloped. A myocardial infarction comprising more than decrease in the total dilatation for ACh, ADPbS, ADP, 30% of the left ventricular wall has in this heart failure ATP and UTP (Table 1, Figs. 1a, 2a, 3a, 4a and 5a) .
model been shown to decrease cardiac output and increase left ventricular end-diastolic pressure [29] . Furthermore, 3.2.5. NO-dilatation the infarct size is positively correlated with left ventricular The NO-dilatation was studied in artery segments volume and negatively correlated with left ventricular pretreated with indomethacin, charybdotoxin and apamin. ejection fraction [31] . Other studies of this heart failure Concentration-dependent dilatations, that were significantmodel have revealed increased plasma levels of catecholly lower in CHF as compared to sham operated rats, could amines and ANP, as well as pulmonary oedema, hepatic be observed for ACh, ADPbS, ADP, ATP and UTP (Table  congestion and pleural effusion [26, 32, 33] . The present 2, Figs. 1c, 2c, 3c, 4b and 5c) . study shows increased heart-(0.34% of total body weight vs. 0.49%, sham operated vs. CHF) and lung-weights 3.2.6. EDHF-dilatation (0.41% vs. 0.69%) in CHF rats. Earlier studies of this heart EDHF-dilatation was studied in artery segments prefailure model have shown that the impairment of the left treated with indomethacin and L-NOARG. ACh-, ADP-, ventricular function is directly related to the loss of myocardium [29] , with the infarction-sizes being divided of the left ventricle (referring to the method described into small (5-19%), moderate (20-39%) and large above) results in a pump-dysfunction with reduced values (.40%) [34] . Loss of more then 30% of the myocardium of peak flow, systolic and mean arterial pressure. The above. Our model can therefore be considered successful according to CHF criteria denoted by the literature. We used this model to examine the endothelial function in CHF by investigating potential alterations in ACh-and P2Y-receptor-stimulated EDHF-and NO-dilatation. [18]. In conductance vessels, flow-dependent dilatation is reduced. These findings reflect endothelial dysfunction in damage of the left ventricular wall was in the present study CHF. The ACh-stimulated release of NO is impaired while histologically proven, and showed a myocardial infarction the bloodflow response to nitroglycerin or sodium nitrocomprising 3864% of the endocardial circumference.
prusside, both endothelium-independent vasodilators, is Also, we noted signs of organic congestion as described preserved indicating a normal response of the VSMC's to ADPbS, ADP, ATP and UTP, indicating a CHF induced endothelial dysfunction (Table 2, Figs. 1b, 2b, 3b, 4b and 5b). The NO-donor SIN-1 induced relaxations that were unaffected by CHF, indicating preserved VSMC response to exogenous NO. The total dilatation of the vessel, induced by ACh and P2Y-receptor stimulation, was slightly decreased, indicating general endothelial dysfunction (Table 1, Figs. 1a, 2a,  3a, 4a and 5a) . The decrease in total dilatation was not as pronounced as for the NO-dilatation, indicating a mechanism that compensates for the decreased NO-effect.
EDHF-dilatation
The vasodilatory effects of ACh have so far mainly been ascribed to NO and prostaglandins. Since Taylor and Weston [35] demonstrated endothelium-dependent relaxation by a factor that could cause relaxation by increasing the membrane potential of the VSMC's, it has been generally accepted that ACh also induce release of EDHF. Although the identity of EDHF remains unknown it has been proposed that EDHF represents epoxyeicosanoic acids [36] . According to the criteria denoted by the literature identification of EDHF requires evidence that it is released by the endothelium, not inhibited by antagonists of NO-synthetase or cyclo-oxygenase pathways and that it induces hyperpolarisation and relaxation of VSMC's that can be blocked by the potassium channel inhibitors charybdotoxin and apamin [37] [38] [39] [40] . In the mesenteric artery activation of P2Y-receptors induce endotheliumdependent vasodilatation mediated by a factor distinct from NO and prostacyclin that is blocked by charybdotoxin and apamin indicating that it is EDHF [5] . This was confirmed by electrophysiological experiments in which both ACh and P2Y-receptor agonists induce endothelium dependent hyperpolarisation of the VSMC's [6] . The hyperpolarisations were antagonised by charybdotoxin and apamin, confirming the use of this combination to inhibit EDHF.
The present study shows endothelium-dependent dilatations, distinct from NO and prostacyclin, to ACh, ADPbS, ADP and UTP since they were not blocked by L-NOARG and indomethacin. A combination of charybdotoxin and apamin totally abolished these dilatations indicating that they were mediated by EDHF. The high concentration of vasodilators acting independently of the endothelium. They did not modify the relaxation to the NO-donor SIN-1 and exogenous NO (Drexler and Hornig, 1996) . In accordance thus we conclude that they do not affect the direct NOto this, our experiments demonstrate a decreased NOmediated activation of the VSMC's [5] . dilatation for ACh, and for the P2Y-receptor agonists ACh, ADPbS-, ADP-and UTP-induced EDHF-dilata- Previous reports suggest that decreased levels of NO tions were not as effective as previously shown in young may be associated with increased activity of EDHF [21] . healthy rats [5] . These differences might be age-related as During physiological conditions, the production of EDHF the rats used in this previous study were approximately is damped by NO. Impaired NO-synthesis, alleviates this 300 g lighter. Previous reports have shown that the intrinsic inhibition of EDHF and endothelial vasodilator vasodilator response to ACh decreases with age, which is function is maintained [43] . Up-regulated EDHF-activity 1 due to inactivation of K channels, while the NO-mediated may compensate for an increased vascular tonus elicited by dilatation is preserved [42] . The lack of ATP-mediated decreased NO-synthesis in hypercholesterolemia [23] and EDHF-dilatation in both CHF and sham operated rats hypertension [21] , or by increased vasoconstriction in depends on simultaneous ATP-activation of contractile diabetes [22] . Our experiments showed EDHF-mediated P2X-receptors on the VSMC's [6] . ATP in the circulation dilatations that were several-fold stronger in the CHF rats mediates vasodilatation through its degradation product for ACh, ADPbS, ADP and UTP (Table 3 , Figs. 1c, 2c, 3c ADP, acting on endothelial ADP-preferring P2Y -recepand 5c). We therefore speculate that a compensatory up-1 tors. UTP on the other hand mediates dilatation via regulation of EDHF-mediated dilatation may represent a pyrimidine-sensitive P2Y-receptors on the endothelium balancing adaptation to endothelial dysfunction and de-(P2Y , P2Y or P2Y ).
creased NO-release and tissue perfusion in CHF (Fig. 6 ). 2 4 6 The mechanism underlying the increased EDHF-dilatation is not known. It could depend on an enhanced synthesis of EDHF triggered by reduced levels of NO or by some of the many humoral factors that are increased in CHF. On the other hand the up-regulated EDHF-dilatation might depend on a greater responsiveness of the VSMC's to EDHF.
Conclusions
The present study demonstrates that CHF induces a tions are down-regulated (Fig. 6) . The increased EDHF- 
